Holdings

Decheng Capital LLC

As of Sep 30, 2026, Decheng Capital LLC reported 10 positions worth US$678M. Largest: CG Oncology, Inc., Nuvation Bio Inc. and Aclaris Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
CG Oncology, Inc.6.37MUS$452Mno changeSep 30, 2026
Nuvation Bio Inc.26MUS$145Mno changeSep 30, 2026
Aclaris Therapeutics, Inc.4.04MUS$21.3Mno changeSep 30, 2026
Aardvark Therapeutics, Inc.3.92MUS$20.6Mno changeSep 30, 2026
Upstream Bio, Inc.2.72MUS$14.4Mno changeSep 30, 2026
Arcus Biosciences, Inc.425KUS$11M−39,700Sep 30, 2026
Equillium, Inc.4.45MUS$7.23Mno changeSep 30, 2026
Zentalis Pharmaceuticals, Inc.1.32MUS$3.67Mno changeSep 30, 2026
BeyondSpring, Inc.3.07MUS$2.36M−735KSep 30, 2026
Pyxis Oncology, Inc.327KUS$761Kno changeSep 30, 2026